{
    "id": 13521,
    "fullName": "ABL2 Y399C",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ABL2 Y399C lies within the protein kinase domain of the Abl2 protein (UniProt.org). Y399C has been identified in the scientific literature (PMID: 26758680), but has not been biochemically characterized and therefore, its effect on Abl2 protein function is unknown (PubMed, Jan 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 6310,
                    "pubMedId": 26758680,
                    "title": "Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26758680"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 27,
        "geneSymbol": "ABL2",
        "terms": [
            "ABL2",
            "ABLL",
            "ARG"
        ]
    },
    "variant": "Y399C",
    "createDate": "11/02/2015",
    "updateDate": "01/20/2020",
    "referenceTranscriptCoordinates": {
        "id": 131075,
        "transcript": "NM_007314",
        "gDna": "chr1:g.179118614T>C",
        "cDna": "c.1196A>G",
        "protein": "p.Y399C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8795,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sprycel (dasatinib) did not inhibit viability of lung adenocarcinoma cells harboring ABL2 Y399C in culture (PMID: 26758680).",
            "molecularProfile": {
                "id": 13706,
                "profileName": "ABL2 Y399C"
            },
            "therapy": {
                "id": 717,
                "therapyName": "Dasatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 6310,
                    "pubMedId": 26758680,
                    "title": "Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26758680"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8796,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib mesylate) did not inhibit viability of lung adenocarcinoma cells harboring ABL2 Y399C in culture (PMID: 26758680).",
            "molecularProfile": {
                "id": 13706,
                "profileName": "ABL2 Y399C"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 6310,
                    "pubMedId": 26758680,
                    "title": "Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26758680"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 13706,
            "profileName": "ABL2 Y399C",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 131074,
            "transcript": "NM_001168237",
            "gDna": "chr1:g.179118614T>C",
            "cDna": "c.1196A>G",
            "protein": "p.Y399C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 131076,
            "transcript": "XM_017001035",
            "gDna": "chr1:g.179118614T>C",
            "cDna": "c.1196A>G",
            "protein": "p.Y399C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 131075,
            "transcript": "NM_007314",
            "gDna": "chr1:g.179118614T>C",
            "cDna": "c.1196A>G",
            "protein": "p.Y399C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}